Alpha 2.0
Login Register
» Articles » PMID: 23946565

Bone Grafts in Dentistry

Overview
Journal J Pharm Bioallied Sci
Specialty Pharmacology
Date 2013 Aug 16
PMID 23946565
Citations 73
Authors
Prasanna Kumar
Belliappa Vinitha
Ghousia Fathima
Affiliations
Soon will be listed here.
Abstract

Bone grafts are used as a filler and scaffold to facilitate bone formation and promote wound healing. These grafts are bioresorbable and have no antigen-antibody reaction. These bone grafts act as a mineral reservoir which induces new bone formation.

Citing Articles

Challenges and Innovations in Alveolar Bone Regeneration: A Narrative Review on Materials, Techniques, Clinical Outcomes, and Future Directions.

Marian D, Toro G, DAmico G, Trotta M, DAmico M, Petre A Medicina (Kaunas). 2025; 61(1).

PMID: 39859003 PMC: 11766548. DOI: 10.3390/medicina61010020.

Optimizing Bone Regeneration with Demineralized Dentin-Derived Graft Material: Impact of Demineralization Duration in a Rabbit Calvaria Model.

Lee B, Choi H, Sohn D J Funct Biomater. 2024; 15(11).

PMID: 39590535 PMC: 11595468. DOI: 10.3390/jfb15110331.

Silver Nanoparticles and Simvastatin-Loaded PLGA-Coated Hydroxyapatite/Calcium Carbonate Scaffolds.

Nocchetti M, Piccotti C, Piccinini M, Caponi S, Mattarelli M, Pietrella D Nanomaterials (Basel). 2024; 14(20).

PMID: 39452973 PMC: 11510553. DOI: 10.3390/nano14201637.

Navigating the combinations of platelet-rich fibrin with biomaterials used in maxillofacial surgery.

Ievina L, Dubnika A Front Bioeng Biotechnol. 2024; 12:1465019.

PMID: 39434715 PMC: 11491360. DOI: 10.3389/fbioe.2024.1465019.

An Up-to-Date Review of Materials Science Advances in Bone Grafting for Oral and Maxillofacial Pathology.

Nicolae C, Pirvulescu D, Niculescu A, Epistatu D, Mihaiescu D, Antohi A Materials (Basel). 2024; 17(19).

PMID: 39410353 PMC: 11478239. DOI: 10.3390/ma17194782.

References
1.
Bansal S, Chauhan V, Sharma S, Maheshwari R, Juyal A, Raghuvanshi S . Evaluation of hydroxyapatite and beta-tricalcium phosphate mixed with bone marrow aspirate as a bone graft substitute for posterolateral spinal fusion. Indian J Orthop. 2009; 43(3):234-9. PMC: 2762171. DOI: 10.4103/0019-5413.49387. View
2.
Valdes M, Thakur N, Namdari S, Ciombor D, Palumbo M . Recombinant bone morphogenic protein-2 in orthopaedic surgery: a review. Arch Orthop Trauma Surg. 2009; 129(12):1651-7. DOI: 10.1007/s00402-009-0850-8. View
3.
Laurencin C, Khan Y, El-Amin S . Bone graft substitutes. Expert Rev Med Devices. 2005; 3(1):49-57. DOI: 10.1586/17434440.3.1.49. View
4.
Waked W, Grauer J . Silicates and bone fusion. Orthopedics. 2008; 31(6):591-7. DOI: 10.3928/01477447-20080601-34. View
5.
Mulconrey D, Bridwell K, Flynn J, Cronen G, Rose P . Bone morphogenetic protein (RhBMP-2) as a substitute for iliac crest bone graft in multilevel adult spinal deformity surgery: minimum two-year evaluation of fusion. Spine (Phila Pa 1976). 2008; 33(20):2153-9. DOI: 10.1097/BRS.0b013e31817bd91e. View